She underwent surgery to remove the tumour. Listen to Story Sharmila Tagore was diagnosed with stage zero lung cancer in 2023 Her cancer was detected early, no chemotherapy needed Sharmila spoke about ...

The 34-year-old Bachelor Nation star — who revealed her diagnosis in February — took to Instagram on Thursday to reveal that her treatment plan no longer includes chemotherapy. 'Imagine you ...

In the OptiTROP-Breast01 phase 3 trial, patients with metastatic triple-negative breast cancer who received the TROP2-targeted antibody–drug conjugate sacituzumab tirumotecan experienced longer ...

A lumbar puncture is a test to check the fluid that circulates around the brain and spinal cord. This is called the cerebrospinal fluid or CSF. A lumbar puncture can check for cancer cells or for ...

Intrathecal gene therapy offers potential for older SMA patients, but safety, efficacy, and patient age considerations are critical. The STEER study evaluates intrathecal therapy's safety and ...

Chemotherapy disrupts brain connectivity in breast cancer patients The decision-making part of the brain undergoes alterations The disruptions worsen as chemotherapy continues A new study in the ...

Summary: New research reveals that chemotherapy can lead to rapid and widespread changes in brain connectivity in breast cancer patients. Using functional MRI scans, scientists observed disruptions in ...

New research published in the Journal of Magnetic Resonance Imaging has uncovered changes in brain connectivity during chemotherapy in patients with breast cancer. In the study of 55 patients with ...

Triple-negative breast cancer (TNBC) is difficult to treat due to its aggressive nature. It often responds initially to chemotherapy but is the most common breast cancer to recur. When it recurs, ...

and intrathecal chemotherapy. “These real-world findings underscore the efficacy of the GMALL protocol in BL management, with outcomes comparable to established regimens but coupled with high ...

Axi-cel, tisa-cel, and brexu-cel were found comparable to other cellular therapy experiences for patients with B-cell ...